[
    {
        "id": "REG-001",
        "category": "Inclusion Criteria",
        "rule": "Protocols must explicitly define age ranges for participants.",
        "risk_level": "High"
    },
    {
        "id": "REG-002",
        "category": "Informed Consent",
        "rule": "The informed consent process must be detailed and aligned with FDA 21 CFR Part 50.",
        "risk_level": "Critical"
    },
    {
        "id": "REG-003",
        "category": "Statistical Analysis",
        "rule": "Sample size calculations must be justified based on power analysis.",
        "risk_level": "Medium"
    },
    {
        "id": "REG-004",
        "category": "Safety Monitoring",
        "rule": "Adverse event reporting timelines must be clearly specified.",
        "risk_level": "High"
    }
]
